MALLINCKRODT FDA Approval NDA 016666

NDA 016666

MALLINCKRODT

FDA Drug Application

Application #016666

Application Sponsors

NDA 016666MALLINCKRODT

Marketing Status

Discontinued001

Application Products

001INJECTABLE;INJECTION0.25mCi/ML0HIPPURAN I 131IODOHIPPURATE SODIUM I-131

FDA Submissions

TYPE 5; Type 5 - New Formulation or New ManufacturerORIG1AP1968-05-24STANDARD
LABELING; LabelingSUPPL6AP1975-12-19STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL8AP1977-07-27STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL9AP1977-08-23STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL10AP1978-04-07STANDARD
LABELING; LabelingSUPPL12AP1982-08-16STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL13AP1982-05-07STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL15AP1998-05-15STANDARD

Submissions Property Types

ORIG1Null0
SUPPL6Null0
SUPPL8Null0
SUPPL9Null0
SUPPL10Null0
SUPPL12Null0
SUPPL13Null0
SUPPL15Null0

CDER Filings

MALLINCKRODT
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 16666
            [companyName] => MALLINCKRODT
            [docInserts] => ["",""]
            [products] => [{"drugName":"HIPPURAN I 131","activeIngredients":"IODOHIPPURATE SODIUM I-131","strength":"0.25mCi\/ML","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"HIPPURAN I 131","submission":"IODOHIPPURATE SODIUM I-131","actionType":"0.25mCi\/ML","submissionClassification":"INJECTABLE;INJECTION","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.